Article Data

  • Views 2567
  • Dowloads 145

Original Research

Open Access

The significance of high-frequency ultrasound-guided breast mass biopsy in the diagnosis of breast cancer

  • J.L. Zhang1,*,
  • J.H. Wang1
  • A.F. Bai1
  • X.Y. Zhang2
  • X.C. Feng1
  • L. Jing1
  • C.L. He1
  • J. Hu1

1Department of Ultrasonography, Yan'an People's Hospital, Yan'an, China

2Department of Internal Medicine, Yan'an People's Hospital, Yan'an, China

DOI: 10.12892/ejgo3814.2017 Vol.38,Issue 5,October 2017 pp.741-744

Published: 10 October 2017

*Corresponding Author(s): J.L. Zhang E-mail: jianleizhangcn@126.com

PDF (179.98 kB) View Full-text

Abstract

Objective: The aim of this study was to explore the clinical application value of high-frequency ultrasound-guided breast mass biopsy in the diagnosis of breast diseases. Materials and Methods: Two hundred patients with breast mass diagnosed clinically and by ultrasound underwent regular color Doppler ultrasound examination on the breast mass and bilateral axillary parts. Then needle biopsy was performed under the guidance of ultrasound and the biopsy tissues were sent to the Department of Pathology for pathological examination. Results: Each patient received biopsy smoothly with a successful puncture rate of 100% under the guidance of ultrasound. No complications occurred, 95% (190/200) of the patients were clearly diagnosed, and 5% (10/200) were orientedly diagnosed. The biopsy examination results were completely consistent with the surgical pathological results in 170 patients, accounted for 85%. Among them, invasive carcinoma in malignant lesions achieved the highest diagnosis coincidence rate (90.1%, 118/131). Conclusion: High frequency ultrasound-guided breast mass biopsy is safe and practical. Its successful rate is high and its pathological results are in high coincidence with the surgical pathological results. Thus, it can provide strong evidence for the diagnosis and identification of benign and malignant breast tumors and for choosing the correct operation scheme.

Keywords

High frequency ultrasound; Breast mass; Biopsy; Breast cancer.

Cite and Share

J.l. Zhang, J.h. Wang, A.f. Bai, X.y. Zhang, X.c. Feng, L. Jing, C.l. He, J. Hu. The significance of high-frequency ultrasound-guided breast mass biopsy in the diagnosis of breast cancer. European Journal of Gynaecological Oncology. 2017; 38(5): 741-744. doi: 10.12892/ejgo3814.2017

References

[1] Zheng S., Bai J.Q., Li J., Fan J.H., Pang Y., Song Q.K. et al.: “The pathologic characteristics of breast cancer in China and its shift during 1999-2008: a national-wide multicenter cross-sectional image over 10 years”. Int. J. Cancer, 2012, 131, 2622.

[2] Youn I., Choi S.H., Moon H.J., Kim M.J., Kim E.K.: “Phyllodes tumors of the breast: ultrasonographic findings and diagnostic performance of ultrasound-guided core needle biopsy”. Ultrasound Med. Biol., 2013, 39, 987.

[3] Levin D.C., Parker L., Schwartz G.F., Rao V.M.: “Percutaneous needle vs surgical biopsy: previous allegations of overuse of surgery are in error”. J. Am. Coll. Radiol., 2012, 9, 137.

[4] O’Flynn E.A., Wilson A.R., Michell M.J.: “Image-guided breast biopsy: state-of-the-art”. Clin. Radiol., 2010, 65, 259.

[5] Fornage B.D.: “Sonographically guided needle biopsy of nonpalpable breast lesions”. J. Clin. Ultrasound, 1999, 27, 385.

[6] Parker S.H., Jobe W.E., Dennis M.A., Stavros A.T., Johnson K.K., Yakes W.F., et al.: “US-guided automated large-core breast biopsy”. Radiology, 1993, 187, 507.

[7] Schoonjans J.M., Brem R.F.: “Fourteen-gauge ultrasonographically guided large-core needle biopsy of breast masses”. J. Ultrasound Med., 2001, 20, 967.

[8] Smith D.N., Rosenfield Darling M.L., Meyer J.E., Denison C.M., Rose D.I., Lester S., et al.: “The utility of ultrasonographically guided large-core needle biopsy: results from 500 consecutive breast biopsies”. J. Ultrasound Med., 2001, 20, 43.

[9] Destounis S.V., Murphy P.F., Seifert P.J., Somerville P.A., Arieno A.L., Morgan R.C., et al.: “Management of patients diagnosed with lobular carcinoma in situ at needle core biopsy at a community-based outpatient facility”. AJR Am. J. Roentgenol., 2012, 198, 281.

[10] Liberman L., Feng T.L., Dershaw D.D., Morris E.A., Abramson A.F.: “US-guided core breast biopsy: use and cost-effectiveness”. Radiology, 1998, 208, 717.

[11] Ibrahim N., Bessissow A., Lalonde L., Mesurolle B., Trop I., Lisbona A., et al.: “Surgical outcome of biopsy-proven lobular neoplasia: is there any difference between lobular carcinoma in situ and atypical lobular hyperplasia”? AJR Am. J. Roentgenol., 2012, 198, 288.

[12] Tothova L., Rauova K., Valkovic L., Vanovcanova L., Lehotska V.: “Stereotactic vacuum-assisted breast biopsy: our experience and comparison with stereotactic automated needle biopsy”. Bratisl. Lek. Listy, 2013, 114, 71.

[13] Crystal P., Koretz M., Shcharynsky S., Makarov V., Strano S.: “Accuracy of sonographically guided 14-gauge core-needle biopsy: results of 715 consecutive breast biopsies with at least two-year followup of benign lesions”. J. Clin. Ultrasound, 2005, 33, 47.

[14] Memarsadeghi M., Pfarl G., Riedl C., Wagner T., Rudas M., Helbich T.H.: “Value of 14-gauge ultrasound-guided large-core needle biopsy of breast lesions: own results in comparison with the literature”. Rofo, 2003, 175, 374.

[15] Sauer G., Deissler H., Strunz K., Helms G., Remmel E., Koretz K., et al.: “Ultrasound-guided large-core needle biopsies of breast lesions: analysis of 962 cases to determine the number of samples for reliable tumour classification”. Br. J. Cancer, 2005, 92, 231.

[16] Schueller G., Jaromi S., Ponhold L., Fuchsjaeger M., Memarsadeghi M., Rudas M., et al.: “US-guided 14-gauge core-needle breast biopsy: results of a validation study in 1352 cases”. Radiology, 2008, 248, 406.

[17] Youk J.H., Kim E.K., Kim M.J., Kwak J.Y., Son E.J.: “Analysis of false-negative results after US-guided 14-gauge core needle breast biopsy”. Eur. Radiol., 2010, 20, 782.

[18] Ricci M.D., Calvano Filho C.M., Oliveira Filho H.R., Filassi J.R., Pinotti J.A., Baracat E.C.: “Analysis of the concordance rates between core needle biopsy and surgical excision in patients with breast cancer”. Rev. Assoc. Med. Bras., 2012, 58, 532.

[19] Nathanson S.D.: “Ultrasound -guided core needle biopsy of axillary lymph nodes in breast cancer”. J. Am. Coll. Surg., 2012, 214, 871.

[20] Gresens A.A., Britt R.C., Feliberti E.C., Britt LD.: “Ultrasound - guided breast biopsy for surgical residents: evaluation of a phantom model”. J. Surg. Educ., 2012, 69, 411.

[21] Apesteguía L., Pina L.J.: “Ultrasound-guided core-needle biopsy of breast lesions”. Insights Imaging, 2011, 2, 493.

[22] Schmidt R.L., Hall B.J., Layfield L.J.: “A systematic review and meta-analysis of the diagnostic accuracy of ultrasound-guided core needle biopsy for salivary gland lesions”. Am. J. Clin. Pathol., 2011, 136, 516.

[23] Taki S., Kakuda K., Kakuma K., Annen Y., Kiyohara K., Kosugi M.: “US-guided core biopsy of the breast with an automated biopsy gun: comparison with an aspiration core needle device”. Nihon Igaku Hoshasen Gakka Zasshi, 1997, 57, 1.

Submission Turnaround Time

Top